Suppr超能文献

地塞米松和皮质醇对抑郁症患者及健康受试者垂体-肾上腺轴的抑制作用:一项剂量反应研究。

Inhibition of the pituitary-adrenal axis with dexamethasone and cortisol in depressed patients and healthy subjects: a dose-response study.

作者信息

Gispen-de Wied C C, D'Haenen H, Verhoeven W M, Wynne H J, Westenberg H G, Thijssen J H, Van Ree J M

机构信息

Department of Psychiatry, Academic Hospital, Utrecht, The Netherlands.

出版信息

Psychoneuroendocrinology. 1993;18(3):191-204. doi: 10.1016/0306-4530(93)90004-5.

Abstract

Different doses dexamethasone (0.25, 0.5, and 1 mg) or cortisol (30, 60, and 120 mg) were administered PO at 2230h to 39 depressed patients and 20 healthy subjects on nonsuccessive days. The inhibiting capacity of the two steroids on hypothalamo-pituitary axis (HPA) function was evaluated by measuring the plasma levels of cortisol, ACTH, and beta-endorphin at 0900h and 1530h each day following treatment. Baseline levels of the hormones were measured before starting treatment. A dose-dependent suppressive effect of both steroids on the plasma levels of cortisol, ACTH, and beta-endorphin was found both in patients and controls, except for the 0900h levels of cortisol after cortisol treatment. The effects were most profound in the morning. Differences between patients and controls were observed after cortisol treatment, but not dexamethasone, with respect to cortisol, ACTH, and beta-endorphin plasma levels in the morning. Cortisol treatment discriminated dexamethasone nonsuppressors from suppressors (patients and controls) and patients categorized as dexamethasone suppressors from controls in a way that dexamethasone treatment could not. The data favour the idea of impaired corticosteroid feedback beyond the pituitary level as part of HPA dysfunction.

摘要

在非连续的日子里,于22:30给39名抑郁症患者和20名健康受试者口服不同剂量的地塞米松(0.25、0.5和1毫克)或皮质醇(30、60和120毫克)。通过在治疗后每天的09:00和15:30测量血浆皮质醇、促肾上腺皮质激素(ACTH)和β-内啡肽水平,评估这两种类固醇对下丘脑-垂体轴(HPA)功能的抑制能力。在开始治疗前测量激素的基线水平。在患者和对照组中均发现,两种类固醇对血浆皮质醇、ACTH和β-内啡肽水平均有剂量依赖性抑制作用,但皮质醇治疗后09:00的皮质醇水平除外。这些作用在早晨最为显著。在早晨,关于皮质醇、ACTH和β-内啡肽的血浆水平,在皮质醇治疗后观察到患者与对照组之间存在差异,但地塞米松治疗后未观察到差异。皮质醇治疗能够区分地塞米松非抑制者与抑制者(患者和对照组),以及将归类为地塞米松抑制者的患者与对照组区分开来,而地塞米松治疗则无法做到这一点。数据支持这样一种观点,即作为HPA功能障碍的一部分,垂体水平以上的皮质类固醇反馈受损。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验